Patent details

Basic Information

Publication number:

EP2307435

PCT Application Number:

PCT/US/2009/049838

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP097901177

PCT Publication Number:

WO/2010/005986

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SALTS OF HIV INHIBITOR COMPOUNDS

French Title of Invention:

SELS DE COMPOSÉS INHIBITEURS DU VIH

German Title of Invention:

SALZE VON HIV-INHIBITORVERBINDUNGEN

SPC Number:

Dates

Filing date:

07/07/2009

Grant date:

13/06/2012

EP Publication Date:

13/06/2012

PCT Publication Date:

14/01/2010

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/04/2011

EP B1 Publication Date:

13/06/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

07/07/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/07/2009

 

 

Name:

Gilead Sciences Inc.

Address:

333 Lakeside Drive, Foster City, CA 94404, United States (US)

Agent

Name:

VALIPAT

From:

11/09/2012

Address:

Avenue Louise 54, 1050, Bruxelles, Belgium (BE)

To:

Inventor

1

Name:

POLNIASZEK Richard, P.

Address:

United States (US)

2

Name:

GRAETZ Benjamin, R.

Address:

United States (US)

Priority

Priority Number:

78989

Priority Date:

08/07/2008

Priority Country:

United States (US)

Classification

Main IPC Class:

C07H 19/20;

Annual Fees

Annual Fee Due Date:

31/07/2026

Annual Fee Number:

18

Annual Fee Amount:

262 Euro

Expected Payer:

Last Annual Fee Payment Date:

25/06/2025

Last Annual Fee Paid Number:

17

Last Annual Fee Paid Amount:

246 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
13/03/2026	Request For Change	5
16/03/2026	Outgoing Correspondence	46